RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
WMBLX
Price
$13.92
Change
+$0.02 (+0.14%)
Updated
Oct 17 closing price
Net Assets
99.23M
Interact to see
Advertisement

RLBCX vs WMBLX

Header iconRLBCX vs WMBLX Comparison
Open Charts RLBCX vs WMBLXBanner chart's image
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
WesMark Balanced
Price$13.92
Change+$0.02 (+0.14%)
VolumeN/A
Net Assets99.23M
RLBCX vs WMBLX Comparison Chart in %
View a ticker or compare two or three
VS
RLBCX vs. WMBLX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBCX is a Buy and WMBLX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 265B vs. WMBLX (99.2M). WMBLX pays higher dividends than RLBCX: WMBLX (1.58) vs RLBCX (1.49). RLBCX was incepted earlier than WMBLX: RLBCX (23 years) vs WMBLX (28 years). WMBLX (1.30) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 44.00 vs. WMBLX (12.00). RLBCX has a lower initial minimum investment than WMBLX: RLBCX (250) vs WMBLX (1000). RLBCX annual gain was more profitable for investors over the last year : 8.34 vs. WMBLX (-2.56). RLBCX return over 5 years is better than : 40.24 vs. WMBLX (16.38).
RLBCXWMBLXRLBCX / WMBLX
Total Expense Ratio0.891.3068%
Annual Report Gross Expense Ratio0.891.3068%
Fund Existence23 years28 years-
Gain YTD14.3647.833183%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets265B99.2M267,137%
Annual Yield % from dividends1.491.5894%
Returns for 1 year8.34-2.56-325%
Returns for 3 years49.2614.85332%
Returns for 5 years40.2416.38246%
Returns for 10 years72.1835.02206%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBM3.520.07
+2.03%
Psyence Biomedical Ltd
CVGW23.810.14
+0.59%
Calavo Growers
SWK67.85-0.06
-0.09%
Stanley Black & Decker
IQ2.03-0.03
-1.46%
iQIYI
PMVP1.40-0.04
-2.78%
PMV Pharmaceuticals